Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

2006507 citationsJournal Article

Authors

René-Olivier Mirimanoff · Ontario Institute for Cancer Research

Thierry Gorlia · Ontario Institute for Cancer Research

Warren Mason · Ontario Institute for Cancer Research

Martin J. van den Bent · Ontario Institute for Cancer Research

Rolf‐Dieter Kortmann · Ontario Institute for Cancer Research

Barbara Fisher · Ontario Institute for Cancer Research

Michele Reni

Abstract

RPA retains its prognostic significance overall as well as in patients receiving RT with or without TMZ for newly diagnosed GBM, particularly in classes III and IV.

Topics & Keywords

Glioma Diagnosis and Treatment Brain Metastases and Treatment Radiomics and Machine Learning in Medical Imaging

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 24, Issue 16, pp. 2563-2569

DOI: 10.1200/jco.2005.04.5963

Field-Weighted Citation Impact: 15.00